Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Bulgaria Czechia Denmark France Germany +8
  • Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

    Recruiting

    1 1 1
    Investigated diseases:
    Italy Spain
  • Study of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy Poland Spain
  • Study on Stopping Dasatinib in Patients with Chronic Myeloid Leukemia After a Previous Attempt to Stop Treatment

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France The Netherlands
  • Study of Asciminib treatment for patients with Chronic Myeloid Leukemia who have T315I mutation and cannot take or tolerate ponatinib

    Recruiting

    1 1 1
    Investigated drugs:
    France
  • Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium France Italy The Netherlands Spain Sweden
  • Study on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia

    Recruiting

    1 1 1
    France Germany Greece Hungary Italy The Netherlands +1
  • Safety and effectiveness of ponatinib and asciminib in chronic myeloid leukemia patients resistant to these drugs

    Not yet recruiting

    1 1 1
    Spain
  • Asciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Poland Spain
  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Not yet recruiting

    1 1 1 1
    France